Ya-Chu Yang | Searcharxiv

arXiv2025

Enhancing Drug Discovery: Quantum Machine Learning for QSAR Prediction with Incomplete Data

Qualitative structure-activity relationship (QSAR) is important for drug discovery and offers valuable insights into the biological interactions of potential drug candidates. It has been demonstrated that QSAR can be accurately predicted by machine learning. However, data with poor quality and limited availability are always the most common and critical issues for medical-related applications for machine learning. In this manuscript, we aim to discuss the performance of classical and quantum classifiers in QSAR prediction and attempt to demonstrate the quantum advantages in the generalization power of the quantum classifier under conditions of limited data availability and a reduced number of features. By applying different data embedding methods followed by feature selection through principal component analysis (PCA), we find that the quantum classifier outperforms the classical one when a small number of features are selected and the number of training samples is limited. The generality of quantum advantages in other open datasets is also explored.

quant-ph↗

arXiv2023

Exploring the Advantages of Quantum Generative Adversarial Networks in Generative Chemistry

De novo drug design with desired biological activities is crucial for developing novel therapeutics for patients. The drug development process is time and resource-consuming, and it has a low probability of success. Recent advances in machine learning and deep learning technology have reduced the time and cost of the discovery process and therefore, improved pharmaceutical research and development. In this paper, we explore the combination of two rapidly-developing fields with lead candidate discovery in the drug development process. First, Artificial intelligence has already been demonstrated to successfully accelerate conventional drug design approaches. Second, quantum computing has demonstrated promising potential in different applications, such as quantum chemistry, combinatorial optimizations, and machine learning. This manuscript explores hybrid quantum-classical generative adversarial networks (GAN) for small molecule discovery. We substituted each element of GAN with a variational quantum circuit (VQC) and demonstrated the quantum advantages in the small drug discovery. Utilizing a VQC in the noise generator of a GAN to generate small molecules achieves better physicochemical properties and performance in the goal-directed benchmark than the classical counterpart. Moreover, we demonstrate the potential of a VQC with only tens of learnable parameters in the generator of GAN to generate small molecules. We also demonstrate the quantum advantage of a VQC in the discriminator of GAN. In this hybrid model, the number of learnable parameters is significantly less than the classical ones, and it can still generate valid molecules. The hybrid model with only tens of training parameters in the quantum discriminator outperforms the MLP-based one in terms of both generated molecule properties and the achieved KL divergence.

quant-ph↗